share on:

South Africa and in Brazil will human trials for a Covid-19 vaccine developed by Oxford University

Some 2,000 people in South Africa will be involved in what is widely considered to be one of the earliest and most advanced trials for a vaccine to tackle the pandemic.

According to BBC, the first doses of the vaccine are being administered in Johannesburg this week. South Africa has been chosen, not just for its expertise in this field, but because Covid-19 is now spreading fast.

That makes it far easier for scientists to find a community at immediate risk of infection, and to then tell whether the British vaccine is effective.

Similar tests are already underway in the UK, but the infection rate there is slowing. Hence the move, not just to South Africa, but to Brazil too, where 5,000 people will be involved in the vaccine trial.

share on:
Black wash

Black wash

Blackwash is home to news, events, entertainment, inspiration and the rich cultural assemblage of the man and woman of colour. Blackwash echoes the beauty, struggles and successes of black people in Nigeria and diaspora. Every day, Blackwash publishes contents that impact lives spiritually, intellectually and professionally. Blackwash is powered by PROJECT MANAGEMENT HUB BN 2522711.

Leave a Reply

share on: